Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30074144HIVENSG00000124275.15protein_codingMTRRNoNo4552Q9UBK8
TVIS30061858HIVENSG00000124275.15protein_codingMTRRNoNo4552Q9UBK8
TVIS30061859HIVENSG00000124275.15protein_codingMTRRNoNo4552Q9UBK8
TVIS30061860HIVENSG00000124275.15protein_codingMTRRNoNo4552Q9UBK8
TVIS30061861HIVENSG00000124275.15protein_codingMTRRNoNo4552Q9UBK8
TVIS20068237HPVENSG00000124275.15protein_codingMTRRNoNo4552Q9UBK8
TVIS44030127HTLV-1ENSG00000124275.15protein_codingMTRRNoNo4552Q9UBK8
TVIS44014688HTLV-1ENSG00000124275.15protein_codingMTRRNoNo4552Q9UBK8
TVIS44003968HTLV-1ENSG00000124275.15protein_codingMTRRNoNo4552Q9UBK8
TVIS44050471HTLV-1ENSG00000124275.15protein_codingMTRRNoNo4552Q9UBK8
TCGA Plot Options
Drug Information
GeneMTRR
DrugBank IDDB00134
Drug NameMethionine
Target IDBE0000763
UniProt IDQ9UBK8
Regulation Typeproduct of
PubMed IDs17079868; 17101561; 17369066
CitationsKim DJ, Park BL, Koh JM, Kim GS, Kim LH, Cheong HS, Shin HD, Hong JM, Kim TH, Shin HI, Park EK, Kim SY: Methionine synthase reductase polymorphisms are associated with serum osteocalcin levels in postmenopausal women. Exp Mol Med. 2006 Oct 31;38(5):519-24.@@Tvedegaard KC, Rudiger NS, Pedersen BN, Moller J: Detection of MTRR 66A-->G polymorphism using the real-time polymerase chain reaction machine LightCycler for determination of composition of allele after restriction cleavage. Scand J Clin Lab Invest. 2006;66(8):685-93.@@Elmore CL, Wu X, Leclerc D, Watson ED, Bottiglieri T, Krupenko NI, Krupenko SA, Cross JC, Rozen R, Gravel RA, Matthews RG: Metabolic derangement of methionine and folate metabolism in mice deficient in methionine synthase reductase. Mol Genet Metab. 2007 May;91(1):85-97. Epub 2007 Mar 21.
GroupsApproved; Nutraceutical
Direct ClassificationMethionine and derivatives
SMILESCSCC[C@H](N)C(O)=O
PathwaysDemeclocycline Action Pathway; Spermidine and Spermine Biosynthesis; Lincomycin Action Pathway; Gentamicin Action Pathway; Josamycin Action Pathway; Methionine Adenosyltransferase Deficiency; Methacycline Action Pathway; Non-Ketotic Hyperglycinemia; Clarithromycin Action Pathway; Betaine Metabolism; Paromomycin Action Pathway; Minocycline Action Pathway; Lymecycline Action Pathway; Glycine and Serine Metabolism; Troleandomycin Action Pathway; Amikacin Action Pathway; Oxytetracycline Action Pathway; Tetracycline Action Pathway; Methionine Metabolism; Spectinomycin Action Pathway; Doxycycline Action Pathway; Dihydropyrimidine Dehydrogenase Deficiency (DHPD); Cystathionine beta-Synthase Deficiency; Telithromycin Action Pathway; Roxithromycin Action Pathway; Tigecycline Action Pathway; Sarcosine Oncometabolite Pathway; Sarcosinemia; Arbekacin Action Pathway; Chloramphenicol Action Pathway
PharmGKBPA450423
ChEMBLCHEMBL42336